Women who started at a normal weight or had smoked in the past were at the highest risk if their waist got bigger over six years.
Scientific Claim
The association between increased waist circumference and higher mortality/cardiometabolic risk is stronger in women who had normal weight at baseline and in ever-smokers.
Original Statement
“Associations between increase in WC and outcomes were restricted to women with normal weight at baseline and to ever‐smokers.”
Evidence Quality Assessment
Claim Status
overstated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The abstract uses 'restricted to' to describe subgroup findings, which is observational. 'Associated' is the correct verb strength; 'restricted to' may imply exclusivity beyond what the data confirm.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Systematic Review & Meta-AnalysisLevel 1aWhether the heightened risk of waist gain in normal-weight women and ever-smokers is reproducible across diverse cohorts.
Whether the heightened risk of waist gain in normal-weight women and ever-smokers is reproducible across diverse cohorts.
What This Would Prove
Whether the heightened risk of waist gain in normal-weight women and ever-smokers is reproducible across diverse cohorts.
Ideal Study Design
Meta-analysis of 10+ prospective cohorts (n>30,000 women) stratifying by baseline BMI category (normal weight <25 kg/m²) and smoking history (ever vs. never), reporting HRs for CVD and mortality by 6-year WC change.
Limitation: Cannot determine biological mechanisms behind subgroup differences.
Prospective Cohort StudyLevel 2bIn EvidenceWhether waist gain in normal-weight women and ever-smokers independently predicts outcomes after adjusting for confounders.
Whether waist gain in normal-weight women and ever-smokers independently predicts outcomes after adjusting for confounders.
What This Would Prove
Whether waist gain in normal-weight women and ever-smokers independently predicts outcomes after adjusting for confounders.
Ideal Study Design
Prospective cohort of 8,000 women (4,000 normal weight, 4,000 overweight/obese; 4,000 ever-smokers, 4,000 never-smokers) with 6-year WC measurements and 15-year follow-up for CVD/mortality, with subgroup interaction testing.
Limitation: Cannot prove why these subgroups are more vulnerable.
Nested Case-Control StudyLevel 3bWhether women who developed CVD or died within normal-weight or ever-smoker subgroups had greater waist gain than matched controls.
Whether women who developed CVD or died within normal-weight or ever-smoker subgroups had greater waist gain than matched controls.
What This Would Prove
Whether women who developed CVD or died within normal-weight or ever-smoker subgroups had greater waist gain than matched controls.
Ideal Study Design
Nested case-control within the cohort: 300 cases (CVD/death) and 600 controls, stratified by baseline BMI and smoking status, comparing 6-year WC change using conditional logistic regression.
Limitation: Cannot establish temporal sequence if measurements are not prospectively timed.
Evidence from Studies
Supporting (1)
This study found that for women who started out at a normal weight or who had smoked before, gaining weight around the waist was a bigger warning sign for health problems than for others. So yes, the claim is right.